A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

August 15, 2022

Primary Completion Date

March 29, 2023

Study Completion Date

March 29, 2023

Conditions

Healthy Participants

Interventions

DRUG

PF-07291177

PF-07291177 will be prepared as an oral solution and/or suspension given in escalating single doses to be determined

DRUG

Placebo

Matching placebo will be prepared as an oral solution and/or suspension given in each cohort